NIVABUPA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

IntraDay Trade Rating: 2.8

💹 Optimal Buy Price: ₹75.0–₹76.0 (below current price and near intraday support)

🎯 Profit Target: ₹78.5–₹79.5 (resistance zone near 50 DMA)

🛡️ Stop Loss: ₹73.5 (below recent support and psychological level)

📊 Exit Strategy if Already Holding: Consider exiting near ₹78.8 if RSI approaches 50 and MACD flattens. Watch for price rejection near ₹79 and volume spikes.

✅ Positive

• 📊 Volume today (1.25 Cr) is significantly higher than 1-week average (52.8L), indicating speculative interest
• 📉 Debt-to-equity ratio of 0.07 reflects low financial leverage
• 📈 DII holding increased by 0.25%, showing mild domestic institutional support
• 📈 PAT improved from ₹-91.4 Cr to ₹-35.3 Cr, showing reduced losses

⚠️ Limitation

• 📉 RSI at 46.5 and MACD at -1.55 indicate weak momentum
• 📉 Stock trading below both 50 DMA and 200 DMA, showing technical pressure
• 📉 P/E of 152 vs industry average of 45.1 suggests extreme overvaluation
• 📉 PEG ratio of 3.38 indicates expensive growth expectations
• 📉 ROCE (7.45%) and ROE (8.18%) are modest for the sector

🚫 Company Negative News

• 📉 Continued quarterly losses and profit variation of -371% raise concerns about financial stability

📢 Company Positive News

• 📈 EPS of ₹0.51 and improving quarterly performance may attract short-term speculative interest
• 📊 Price action near 52-week low (31.8% index) could trigger technical bounce

🏭 Industry

• 🏥 NIVABUPA operates in the health insurance sector, which benefits from rising healthcare awareness and regulatory support
• 📈 Industry P/E of 45.1 supports long-term valuation potential for profitable peers

🧾 Conclusion

📌 NIVABUPA presents a speculative intraday setup with high volume and potential bounce from oversold levels, but weak fundamentals and technical indicators limit conviction. Traders may consider entering near ₹75.5 with a target of ₹78.8 and stop loss at ₹73.5. If already holding, monitor RSI and MACD for exit signals near resistance.

I can also help you compare NIVABUPA’s setup with other insurance stocks like Star Health or ICICI Lombard to identify stronger intraday candidates.